Amyloid deposited in the brains of Alzheimer's disease (AD) patients is composed of a 4kDa amyloid beta peptide or A-beta. A-beta is produced by sequential cleavage of the amyloid precursor protein (APP) by beta- and gamma-secretases. A novel type-1 integral membrane aspartyl protease BACE has been identified as the beta-secretase, and knock-out mouse models demonstrate that this enzyme is necessary for A-beta production in the mouse brain. The generation of A-beta by beta-secretase is a minor pathway of APP processing, resulting in 10% of APP processing to its secreted derivatives. Since BACE is a poorly active enzyme in vitro, it has been proposed that its activity is limiting in the cell. However, A-beta production increases by several orders of magnitude in transfected cells expressing high levels of APP without a corresponding increase in BACE activity. To explain these discrepant observations, the PI proposes the hypothesis that APP processing by BACE occurs in a specialized cellular compartment where its activity is not limiting. Instead, only a small pool of APP enters this compartment, accounting for the limiting processing of APP by BACE. This hypothesis is consistent with recent findings from the PI's laboratory indicating that BACE can be isolated as highly active high molecular weight complex from guinea pig brain. To further test this hypothesis, in aim 1 APP chimeras will be generated to target APP to specialized cellular compartments, and its processing will be examined.
In aim 2, the effects of cholesterol, a known stimulator of beta-secretase processing, will be evaluated on the levels and activity of BACE complex.
In aim 3, the basis of enhanced BACE activity in the complex will be evaluated. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG023055-05
Application #
7446704
Study Section
Special Emphasis Panel (ZRG1-CDIN (01))
Program Officer
Snyder, Stephen D
Project Start
2004-09-30
Project End
2011-06-30
Budget Start
2008-07-01
Budget End
2011-06-30
Support Year
5
Fiscal Year
2008
Total Cost
$222,492
Indirect Cost
Name
Medical University of South Carolina
Department
Neurosciences
Type
Schools of Medicine
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29425
Pappolla, Miguel; Sambamurti, Kumar; Vidal, Ruben et al. (2014) Evidence for lymphatic A? clearance in Alzheimer's transgenic mice. Neurobiol Dis 71:215-9
Pinnix, Inga; Ghiso, Jorge A; Pappolla, Miguel A et al. (2013) Major carboxyl terminal fragments generated by ?-secretase processing of the Alzheimer amyloid precursor are 50 and 51 amino acids long. Am J Geriatr Psychiatry 21:474-83
Maloney, Bryan; Sambamurti, Kumar; Zawia, Nasser et al. (2012) Applying epigenetics to Alzheimer's disease via the latent early-life associated regulation (LEARn) model. Curr Alzheimer Res 9:589-99
Yu, Jin; Gattoni-Celli, Marco; Zhu, Hong et al. (2011) Vitamin D3-enriched diet correlates with a decrease of amyloid plaques in the brain of A?PP transgenic mice. J Alzheimers Dis 25:295-307
Sambamurti, Kumar; Greig, Nigel H; Utsuki, Tadanobu et al. (2011) Targets for AD treatment: conflicting messages from ?-secretase inhibitors. J Neurochem 117:359-74
Li, Yazhou; Duffy, Kara B; Ottinger, Mary Ann et al. (2010) GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease. J Alzheimers Dis 19:1205-19
Poeggeler, Burkhard; Sambamurti, Kumar; Siedlak, Sandra L et al. (2010) A novel endogenous indole protects rodent mitochondria and extends rotifer lifespan. PLoS One 5:e10206
Ramesh, Balenahalli N; Rao, T S Sathyanarayana; Prakasam, Annamalai et al. (2010) Neuronutrition and Alzheimer's disease. J Alzheimers Dis 19:1123-39
Prakasam, Annamalai; Muthuswamy, Anusuya; Ablonczy, Zsolt et al. (2010) Differential accumulation of secreted AbetaPP metabolites in ocular fluids. J Alzheimers Dis 20:1243-53
Ablonczy, Zsolt; Prakasam, Annamalai; Fant, James et al. (2009) Pigment epithelium-derived factor maintains retinal pigment epithelium function by inhibiting vascular endothelial growth factor-R2 signaling through gamma-secretase. J Biol Chem 284:30177-86

Showing the most recent 10 out of 31 publications